NVO Stock Gains After Parvus Asset Management Builds Stake
Shares of Novo Nordisk NVO gained 5% on June 10, following a report that activist hedge fund Parvus Asset Management is building a stake in the company.
Per the Financial Times, this London-based hedge fund, Parvus Asset Management, is raising its stake in NVO to influence the appointment of the company's new chief executive officer (CEO).
Last month, shares of the company dipped after it announced that CEO Lars Fruergaard Jørgensen would step down from his position following a mutual agreement with the company's board.
Parvus Asset Management did not reveal its exact stake in NVO and is not required to do so if it owns less than 5% of the company, as per Danish securities rules.
While Jørgensen's tenure was quite successful with NVO becoming one of the top players in the obesity market, recent market challenges and a decline in the company's share price since mid-2024 prompted the Novo Nordisk Foundation Board to initiate discussions around a change in leadership. Consequently, Novo Nordisk's board and Jørgensen mutually agreed that a leadership transition would be in the best interest of the company and its shareholders.
Year to date, Novo Nordisk's shares have lost 6.7% against the industry 's growth of 3.1%.
NVO to Post New Semaglutide and CagriSema Results
Novo Nordisk's semaglutide, a GLP-1 agonist, medicines gained significant traction, capturing a dominant share of the market. Among the most notable products are Ozempic injection and Rybelsus oral pill for type 2 diabetes (T2D), and Wegovy, an injection for weight management. Ozempic is also indicated for treating chronic kidney disease and Wegovy received FDA approval last year to reduce the risk of heart disease.
NVO announced that it will present data from the STEP UP trial on a higher dose of Wegovy (semaglutide 7.2 mg) for those in need of greater weight loss. The data will be presented at the upcoming American Diabetes Association (ADA) 85th Scientific Sessions in Chicago, set to be held during June 20-23, 2025.
Management stated that the data will reinforce semaglutide's efficacy in both a clinical and real-world setting, including cardiometabolic and kidney health benefits for those with obesity and diabetes.
Novo Nordisk will also present full results from the phase III REDEFINE 1 and 2 studies on CagriSema.
CagriSema, a fixed-dose combination of a long-acting amylin analogue and Wegovy, is the most advanced candidate in Novo Nordisk's obesity pipeline. Management stated that the REDEFINE 1 and 2 studies will provide insights into the transformational potential of CagriSema.
NVO will also present data on pipeline candidate amycretin, demonstrating its commitment to obesity innovation and individualized healthcare solutions.
Shares likely gained on June 10 due to investors' optimism about the upcoming presentations.
NVO Stock Under Pressure
The recent market challenges have resulted in a decline in NVO's share price. Stiff competition in the obesity market from its arch-rival, Eli Lilly LLY, and pipeline and regulatory setbacks weigh on the share price. NVO's semaglutide drugs have only been off the FDA's supply shortage list since February 2025.
Lilly markets its tirzepatide injections, Mounjaro for T2D, and Zepbound for obesity. It has achieved stupendous success for its obesity drugs.
To tackle the increasing competitive pressure in the industry and diversify from its injectable GLP-1 products, including Wegovy and Ozempic, NVO is rapidly developing new obesity treatments to retain its edge, especially in the lucrative U.S. market. The FDA accepted Novo Nordisk's regulatory application, seeking the approval of oral semaglutide 25 mg for obesity, for review. A final decision from the regulatory body is expected around the turn of the year.
NVO Zacks Rank and Stocks to Consider
Novo Nordisk currently carries a Zacks Rank #3 (Hold). A couple of better-ranked large-cap pharma stocks are Novartis NVS and Bayer BAYRY, both carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate Novartis' 2025 earnings per share (EPS) has risen from $8.46 to $8.74 over the past 60 days. EPS estimates for 2026 have jumped 35 cents to $9.02 during this timeframe. The stock has risen 24.7% so far this year.
BAYRY's 2025 EPS estimate has increased from $1.19 to $1.25 for 2025 over the past 60 days, while that for 2026 has gone up from $1.28 to $1.31 over the same timeframe. Year to date, shares of Bayer have surged 56.7%.
BAYRY's earnings beat estimates in one of the trailing four quarters, matched twice and missed on the remaining occasion, the average negative surprise being 13.91%.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Novartis AG (NVS): Free Stock Analysis Report
Novo Nordisk A/S (NVO): Free Stock Analysis Report
Eli Lilly and Company (LLY): Free Stock Analysis Report
Bayer Aktiengesellschaft (BAYRY): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
Better EV Stock: Ford vs. Tesla
-The comparison between Ford (NYSE: F) and Tesla (NASDAQ: TSLA) is valuable and valid because it speaks to where the auto industry is headed and highlights the relative position of each company as it moves toward electric vehicles and robotaxis. Whether it's a legacy automaker (Ford) or a dedicated battery electric vehicle company(Tesla), the key opportunities and challenges are the same. So, which company is better placed to thrive in the future? Affordable electric vehicles and robotaxis Tesla's launch of its full-self-driving (FSD) robotaxi is sometimes seen as a tactical move as its electric vehicle (EV) sales and market share come under pressure in 2025, but nothing could be further from the truth. The reality is that major automakers, including Ford, and leading technology companies have invested billions in robotaxis and autonomous driving, and it's an integral part of the future of the auto industry. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » The reason behind the investment is a recognition that robotaxis have huge profit potential, not least because they offer a long stream of recurring income from ride-per-mile revenue. Another reality is that EVs are not cheap, and if they are the future of the auto industry, automakers need to make them more affordable. They also need to offer robotaxis to make mobility more affordable. However, don't take my word for it. Here's Ford's CEO Jim Farley in 2019 on autonomous driving and robotaxis: "The self-driving system is incredibly important to develop, but it's just one part of building a safe and scalable self-driving service that consumers can trust." Farley went on to outline a timeline for a "commercial self-driving service" in 2021, which Ford would fail to achieve. As for affordable EVs, last year, Farley reiterated the need to offer smaller and more affordable EVs to achieve profitability as an EV maker. The two things are strongly connected. You can't have robotaxi EVs if the vehicles aren't affordable. That's a point that resonated during a recent CNBC interview with Waymo, which has a robotaxi service already in place, yet co-CEO Tekedra Mawakana declined to outline a timeline for the company's profitability. Waymo's lack of profitability means its owner, Alphabet, is going to have to invest significant sums, at a loss, if it wants Waymo to build scale. That creates a huge opportunity for a company like Tesla that is just entering the market and potentially offers a much more commercial and scalable service. Tesla's advantage in scaling robotaxis lies in its ability to transform existing Tesla vehicles into robotaxis, as well as its capability to produce a dedicated robotaxi, the Cybercab. Unlike Waymo, Tesla doesn't need to partner with automakers to build scale. Moreover, Musk has disclosed that Tesla has been in discussions about licensing its FSD to other automakers -- another route to long-term profitability. Affordable EVs I'll cut to the chase. If Tesla can make automated driving and robotaxis work, then there's only one winner here, and it's Tesla. First, Ford is a long way from having a profitable EV business. For example, its Model E segment lost $5.1 billion in 2024, and then $849 million in the first quarter of 2025. Ford sold 22,550 EVs in the first quarter, implying it lost almost $38,000 on every EV sold. Moreover, its EV models, the Mustang Mach-E, the F-150 Lightning, and the E-Transit, are far from being affordable EVs. In contrast, Tesla generated $7.1 billion in operating profit in 2024. Despite losing market share amid declining sales, it still dominated the U.S. market, holding 43.5% of the market in the first quarter of 2025. Ford was a distant second with 7.7%. Both Ford and Tesla are planning to release low-cost models in the future, but given Ford's ongoing losses, Tesla's profitability, and its ability to lower its average cost per car, down from above $38,000 in early 2023 to below $35,000 in late 2024, the latter looks far better positioned to do so sustainably. Robotaxis and FSD Ford backed off its robotaxi/FSD plans in 2022, following the shutdown of Argo AI by Ford and Volkswagen after years of heavy investment. The company had been created to develop the technology and received billions of dollars in investment from Ford and Volkswagen. For reference, General Motors has also ended robotaxi development. In contrast, Tesla is preparing for the official launch of its unsupervised FSD/robotaxi service in Austin, Texas, this month, and it may be live by the time you read this article. While the launch will be small and highly contained, it still marks the birth of Tesla's robotaxi offering. Musk believes Tesla will have a dedicated, low-cost robotaxi, the Cybercab, in volume production by 2026. Indeed, Ford may end up licensing FSD from Tesla, and to his great credit, Farley has indicated an openness to partnering on FSD. Ford or Tesla? There is no guarantee that Tesla's robotaxi or FSD will be successful, and investors need to closely monitor events. Moreover, Musk has a history of being overly optimistic on such matters. That said, the major automakers have been and are still pursuing the idea of lower-cost EVs and robotaxis and automated driving, and currently, Tesla remains the best-positioned company to meet those aims. It's where the industry wants to be, and Tesla is in pole position. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 994%* — a market-crushing outperformance compared to 172% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
7 hours ago
- Globe and Mail
The UK Is Investigating Amazon (AMZN) for Not Paying Its Suppliers on Time
E-commerce giant Amazon (AMZN) is being investigated by the UK's grocery regulator, the Groceries Code Adjudicator (GCA), for not paying its suppliers on time. This would violate Article 5 of the UK's Groceries Supply Code of Practice, which says that retailers must pay suppliers 'within a reasonable time' after receiving their invoice. If Amazon is found to have breached the code, it could face a fine of up to 1% of its annual grocery turnover in the UK. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The GCA said that it had been monitoring Amazon's actions after warning the company last year to fix its practices. After reviewing more evidence, the regulator decided to launch a formal investigation focused specifically on Amazon's compliance with the payment timing rule. The GCA is responsible for making sure large grocery retailers treat their suppliers fairly, and this move suggests Amazon hasn't done enough to address previous concerns. While Amazon's grocery operations are smaller in the UK than in other markets, they are still significant. Estimates suggest that Amazon has between 1.6% and 3% of the UK grocery market, compared to Tesco's 29%. Amazon doesn't break out UK grocery sales in its earnings reports, but the Competition and Markets Authority requires companies with over £1 billion in UK grocery turnover to follow the Groceries Code, which implies that Amazon exceeds that threshold. Following news of the investigation, Amazon's stock opened lower on Friday and continued to trade in the red for a third straight session. What Is the Price Target for AMZN Stock? Turning to Wall Street, analysts have a Strong Buy consensus rating on Amazon stock based on 46 Buys and one Hold assigned in the past three months. Furthermore, the average AMZN stock price target of $241.64 implies 15% upside potential from current levels. See more AMZN analyst ratings
Globe and Mail
a day ago
- Globe and Mail
DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years
Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France , June 20, 2025 /CNW/ -- DDB Worldwide, part of Omnicom, has once again claimed the prestigious title of Network of the Year at the 2025 Cannes Lions International Festival of Creativity. This marks the second time the network has secured the honor, following its historic first win in 2023. In a record-breaking year, DDB surpassed its 2023 award tally with a total of 112 Lions, further cementing its place at the forefront of the global creative industry. DDB's continued rise comes just one year into the leadership of Global CEO Alex Lubar and President & Global Chief Creative Officer, Chaka Sobhani . Since taking the reins, the duo has steered the network into a new era; one defined by tighter integration, emotionally-led creativity, and a sharpened focus on work that delivers both cultural impact and real business results. Chaka Sobhani commented: "I literally don't have the words. This means the absolute world to us. I couldn't be prouder of our DDB network and the passion, commitment, and love that has gone behind us getting here. A huge thank you also to our amazing clients for their trust and partnership - we wouldn't be here without you and I hope we've made you proud. Hopefully, this is the start of much more to come from DDB - and on a personal note, I can only say it's been the most incredible first year!" "2023 was a landmark year for DDB, but we saw it as the beginning," said Alex Lubar . "The momentum you're seeing now is the result of a global network aligned around a simple belief: creativity is the most powerful force in business. I'm incredibly proud of our exceptional teams and client partners on this collective effort." 2025 Cannes Lions highlights: Regional Network of the Year - Latin America Regional Network of the Year - Pacific Classic Track Agency of the Year - Africa Creative DDB Good Track Agency of the Year - Africa Creative DDB Experience Track Agency of the Year - DM9 Africa Creative DDB is the 1st ranked agency in Brazil , 2nd in Agency of the Year The first time DDB won four Grands Prix across different brands since 2016, including: Audio & Radio: "One Second Ads" (Budweiser, Africa Creative DDB) Music: "Tracking Bad Bunny" (Rimas Entertainment, DDB Latina Puerto Rico) Creative Data: "Efficient Way to Pay" (Consul, DM9) Sustainable Development Goals: "The Amazon Greenventory" (Natura, Africa Creative DDB) 20 total Gold Lions 37 total Silver Lions 51 total Bronze Lions 320 total shortlists First Gold Cannes Lion in Finland for Nordea, Parental Leave Mortgage First Grand Prix for DDB Latina Puerto Rico, and Puerto Rico's second in history First Gold for DDB Warsaw for McDonald's Winter Takes on Color in Brand Experience & Activation Most Lions and Grands Prix won by DDB Latina ever, with 78 trophies vs their previous record of 44 Most awarded network in Brand Experience & Activation with 20 trophies Most awards on behalf of McDonald's than any other agency network This creative surge has been powered by the DDB Global Creative Council, Bullseye, which is led by Global Chief Creative Operations Officer, Susie Walker , and continues to push boundaries across regions. This year, the program has been expanded to include rising creative talent, who have actively shaped DDB's award-winning creative work. DDB's rise has also been fueled by the growing influence of some of its most dynamic agencies, including DDB Paris, Africa Creative DDB, alma, DM9, and NORD DDB, whose bold, culturally resonant work continues to redefine the standard of global creative excellence. As creativity becomes an increasingly vital business differentiator, DDB's Cannes success proves its belief that emotional storytelling not only moves people, it moves markets. This year's winning campaigns have not only earned accolades but delivered measurable growth for clients across categories. ABOUT DDB WORLDWIDE DDB ( is The Emotional Advantage Agency. We believe when people feel, they act—and when they act, brands grow. That's the emotional advantage. We use it to deliver intimacy at scale, unlock brand growth, and craft ideas that move people, business, and culture forward. As one of the world's leading advertising and marketing networks, DDB blends creative excellence with strategic effectiveness to drive measurable results. With 140 offices in 60+ countries, we partner with iconic brands like MARS, McDonald's, Molson Coors , Volkswagen, Amazon, Unilever, JetBlue, Adidas, PlayStation, and the U.S. Army. Our impact is proven: we were named the #1 Most Awarded Agency Network in the 2024 Effie Global Best of the Best, Global Network of the Year by Cannes Lions (2023 and 2025), and D&AD Network of the Year for three consecutive years (2021–2023). We've also ranked as a Top 3 Global Network on WARC for 13 of the last 16 years. Founded in 1949, DDB is part of Omnicom (NYSE: OMC).
